We understand poor pre-formulation studies may lead to delays in pre-clinical and clinical development programs. We can provide you with the solid foundation required for successful transition of early phase development programs through to clinical, using our world-leading expertise in development of methods for inhaled drug product characterisation, As part of our pre-formulation development package we are able to provide you with the following:
Development of assay and stability indicating methods by HPLC/UPLC/LC-MS-MS
Conduct force degradation studies.
Excipient compatibility studies.
Develop methods for determining blend content uniformity of dry powder formulation blends.
Develop methods for delivered dose uniformity and aerodynamic particle size distribution by inertial impaction.
Conduct ICH based stability testing of APIs and finished products.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
